Rib-X Pharmaceuticals Appoints Infectious Disease Expert and Former FDA Deputy Director Matthew Wikler, MD as Chief …

Rib-X Pharmaceuticals, Inc. announced today that the Company has appointed Matthew A. Wikler, M.D. as Chief Development Officer, effective April 30, 2012. Dr. Wikler will assume a